HCRN Directory

Esophageal/Gastric

Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma

Status

Cancer Types

Esophageal/Gastric

Locations

A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination (HR) defective or loss of heterozygosity (LOH) high-metastatic esophageal/GEJ/proximal gastric adenocarcinoma

Status

Cancer Types

Esophageal/Gastric

Locations

Pre-operative Cetuximab and Radiation (XRT) for Patients (pts) with Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Status

Cancer Types

Esophageal/Gastric

Locations

A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation (RT) and Celecoxib in Patients with Resectable Esophageal Cancer (EC)

Status

Cancer Types

Esophageal/Gastric

Locations

A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GEJ junction carcinomas

Status

Cancer Types

Esophageal/Gastric

Locations

Sunitinib plus paclitaxel in patients with advanced esophageal cancer: a phase II study

Status

Cancer Types

Esophageal/Gastric

Locations

A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation (RT) and Celecoxib in Patients with Resectable Esophageal Cancer (EC): Preliminary Results

Status

Cancer Types

Esophageal/Gastric

Locations

Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results

Status

Cancer Types

Esophageal/Gastric

Locations